Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a
promising candidate for the treatment of both somatic and psychiatric disorders. The aim of …

Aims Cannabidiol (CBD) is a cannabis‐derived medicinal product with potential application
in a wide‐variety of contexts; however, its effective dose in different disease states remains …

Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but
there is uncertainty about its safety. We conducted the first systematic review and meta …

Objective Cannabidiol (CBD) has a proposed novel role in the management of anxiety
owing to its actions on the endocannabinoid system. The purpose of this systematic review …

Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing
attention in medicine for its anxiolytic, antipsychotic, antiemetic and anti-inflammatory …

Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …

Cannabidiol (CBD) is a substance chemically derived from Cannabis sativa and discussed
to be non-psychoactive. According to the FDA, marijuana is classified as a schedule I …

Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is
increasing with claims of therapeutic effects across a diversity of health conditions. At …

Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

Background The therapeutic application of cannabidiol (CBD) is gaining interest due to
expanding evidence for its use. Objective To summarize the clinical outcomes, study …